MARKET

KZIA

KZIA

Kazia Therapeuti
NASDAQ
4.380
-0.100
-2.23%
After Hours: 4.520 +0.14 +3.20% 16:42 12/06 EST
OPEN
4.460
PREV CLOSE
4.480
HIGH
4.650
LOW
4.101
VOLUME
135.51K
TURNOVER
--
52 WEEK HIGH
15.80
52 WEEK LOW
1.866
MARKET CAP
19.07M
P/E (TTM)
-0.0592
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at KZIA last week (1125-1129)?
Weekly Report · 12/02 10:30
Weekly Report: what happened at KZIA last week (1118-1122)?
Weekly Report · 11/25 10:25
Weekly Report: what happened at KZIA last week (1111-1115)?
Weekly Report · 11/18 10:23
Kazia Therapeutics Secures Nasdaq Compliance
TipRanks · 11/12 15:40
Weekly Report: what happened at KZIA last week (1104-1108)?
Weekly Report · 11/11 10:31
Kazia Therapeutics management to meet with Maxim
TipRanks · 11/10 22:10
Kazia Therapeutics Advances Paxalisib with FDA Meeting
TipRanks · 11/04 21:59
Kazia Therapeutics announces granting of Type C meeting with FDA
TipRanks · 11/04 12:41
More
About KZIA
Kazia Therapeutics Limited is an oncology focused drug development company. The Company is engaged in the pharmaceutical research and development. Its lead program includes Paxalisib and EVT801. Paxalisib is a small molecule inhibitor of the PI3K / Akt / mTOR pathway, a central regulator of growth and cell division that is dysregulated in many types of cancer. Paxalisib is being developed for several forms of brain cancer. EVT801 is a small molecule inhibitor of vascular endothelial growth factor receptor 3 (VEGFR3), which is critical to the development of new blood vessels and lymphatic vessels in a growing tumor, as well as to the metastasis of tumors to distant sites in the body. EVT801 is an inhibitor of VEGFR3, a cellular receptor for VEGF. The Company’s drug candidates are designed to treat disease, such as brain cancer, renal cancer, and liver cancer.

Webull offers Kazia Therapeutics Ltd (ADR) stock information, including NASDAQ: KZIA real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, KZIA stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading KZIA stock methods without spending real money on the virtual paper trading platform.